Financial News
All News about Immunome Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Announces Proposed Public Offering of Common Stock
February 13, 2024
From Immunome, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Inc. (NASDAQ: IMNM) Leading the Way in Thursday Trading Based on Percentage Gain
June 29, 2023
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2023/06/29/imnm.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Phil Roberts as Chief Technical Officer
January 04, 2024
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Carol A. Schafer to Board of Directors
January 02, 2024
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome to Acquire Antibody-Related Assets and Materials from Atreca
December 26, 2023
From Immunome, Inc.
Via Business Wire
![](https://ml.globenewswire.com/media/72c155be-0ccf-4136-ae5f-b3f5b6fb4b6c/small/atreca-logo-jpg.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome to Present at the Stifel 2023 Healthcare Conference
November 10, 2023
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Reports Third Quarter 2023 Financial Results
November 09, 2023
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Jean-Jacques Bienaimé to Board of Directors
November 08, 2023
From Immunome, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer
October 19, 2023
From Immunome, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Reports Second Quarter 2023 Financial Results
August 09, 2023
From Immunome, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/06/29/acuity_brands_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/29/franklin_covey_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230629890293/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/29/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.